COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ:OSIR), the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets announced today that Lode Debrabandere, Ph.D., President and Chief Executive Officer, is scheduled to present at the 2nd Annual Regen Med Investor Day on Wednesday, March 26, 2014 at 4:15 p.m. ET in New York City.
Help employers find you! Check out all the jobs and post your resume.
